Metformin and cancer mortality

The author analyses recent publications supporting the ability of metformin to decrease the risk of cancer morbidity and mortality in patients with type 2diabetes mellitus. Pre-history of the problem (including the use of biguanides for metabolic rehabilitation of oncological patients), the role of...

Full description

Bibliographic Details
Main Author: Lev Mikhaylovich Bershteyn
Format: Article
Language:English
Published: Endocrinology Research Centre 2010-09-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/5491